209 related articles for article (PubMed ID: 36755690)
21. Serum exosomal microRNA-370-3p and microRNA-196a-5p are potential biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Wei Y; Zhang Q; An L; Fang G; Hong D; Jiao T; Yang H; Wang Z
Folia Histochem Cytobiol; 2022; 60(3):215-225. PubMed ID: 35762276
[TBL] [Abstract][Full Text] [Related]
22. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
[TBL] [Abstract][Full Text] [Related]
23. Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.
Parpart S; Roessler S; Dong F; Rao V; Takai A; Ji J; Qin LX; Ye QH; Jia HL; Tang ZY; Wang XW
Hepatology; 2014 Sep; 60(3):872-83. PubMed ID: 24798303
[TBL] [Abstract][Full Text] [Related]
24. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
[TBL] [Abstract][Full Text] [Related]
25. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
Wang Z; Ding Q; Li Y; Liu Q; Wu W; Wu L; Yu H
Tumour Biol; 2016 Nov; 37(11):14779-14787. PubMed ID: 27633066
[TBL] [Abstract][Full Text] [Related]
26. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.
Yang L; Wei C; Li Y; He X; He M
Biomark Med; 2020 Oct; 14(15):1485-1500. PubMed ID: 33155836
[No Abstract] [Full Text] [Related]
27. GAS5 Regulates RECK Expression and Inhibits Invasion Potential of HCC Cells by Sponging miR-135b.
Yang L; Jiang J
Biomed Res Int; 2019; 2019():2973289. PubMed ID: 30733959
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
29. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
30. Clinical application study on miR-98-5p as a prognostic biomarker in hepatocellular carcinoma.
Ji PT; Wang XY
Clin Res Hepatol Gastroenterol; 2023 Feb; 47(2):102077. PubMed ID: 36623770
[TBL] [Abstract][Full Text] [Related]
31. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
Chen L; Jiang M; Yuan W; Tang H
J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
[TBL] [Abstract][Full Text] [Related]
32. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
Li L; Wang A; Cai M; Tong M; Chen F; Huang L
Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
[TBL] [Abstract][Full Text] [Related]
33. Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis.
Xu J; Zhang Y; Liu C; Yan P; Yang Z
Int J Med Sci; 2021; 18(15):3556-3564. PubMed ID: 34522182
[No Abstract] [Full Text] [Related]
34. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
35. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
[TBL] [Abstract][Full Text] [Related]
36. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
37. Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.
Luo YH; Tang W; Zhang X; Tan Z; Guo WL; Zhao N; Pang SM; Dang YW; Rong MH; Cao J
Medicine (Baltimore); 2017 Jul; 96(30):e7545. PubMed ID: 28746200
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
39. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
Cho HJ; Baek GO; Seo CW; Ahn HR; Sung S; Son JA; Kim SS; Cho SW; Jang JW; Nam SW; Cheong JY; Eun JW
Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma.
Li Y; Xu D; Bao C; Zhang Y; Chen D; Zhao F; Ding J; Liang L; Wang Q; Liu L; Li J; Yao M; Huang S; He X
Oncotarget; 2015 Feb; 6(4):2421-33. PubMed ID: 25537516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]